{"id":38090,"date":"2025-07-29T12:17:15","date_gmt":"2025-07-29T04:17:15","guid":{"rendered":"https:\/\/flcube.com\/?p=38090"},"modified":"2025-07-29T12:17:16","modified_gmt":"2025-07-29T04:17:16","slug":"shanghai-biomedicine-ma-fund-acquires-stake-in-microport-via-share-transfer-agreement","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=38090","title":{"rendered":"Shanghai Biomedicine M&amp;A Fund Acquires Stake in MicroPort via Share Transfer Agreement"},"content":{"rendered":"\n<p>The Shanghai Biomedicine Merger and Acquisition Fund under SIIC Capital has entered into a share transfer agreement to acquire 135,335,204 shares of MicroPort Scientific Corp. (<a href=\"https:\/\/www.google.com\/finance\/quote\/0853:HKG\">HKG: 0853<\/a>) from Otsuka Medical Devices Co., Ltd., a subsidiary of Otsuka Holdings. This transaction positions the Shanghai Biomedicine M&amp;A Fund as a strategic shareholder of MicroPort.<\/p>\n\n\n\n<p><strong>Strategic Investment Objectives<\/strong><br>This investment aligns with the Shanghai Biomedicine M&amp;A Fund&#8217;s role as a &#8220;chain leader&#8221; supporter in the biomedicine industry. The fund aims to support MicroPort&#8217;s development through multiple initiatives:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Facilitating the expansion of core businesses and potential strategic mergers and acquisitions to foster continuous innovation and scale growth.<\/li>\n\n\n\n<li>Unlocking synergistic value to enhance MicroPort&#8217;s cluster and competitive advantages.<\/li>\n\n\n\n<li>Strengthening MicroPort&#8217;s role as a &#8220;chain leader&#8221; to drive the agglomeration of upstream and downstream enterprises in Shanghai, attract high-end talent, and promote breakthroughs in key technologies and core components within the local market.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/li>\n<\/ul>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Shanghai Biomedicine Merger and Acquisition Fund under SIIC Capital has entered into a share&#8230;<\/p>\n","protected":false},"author":1,"featured_media":38092,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10,22],"tags":[20,982,192,4251,4250],"class_list":["post-38090","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","category-medical-device","tag-finance","tag-hkg-0853","tag-microport-scientific","tag-otsuka-medical-devices","tag-shanghai-biomedicine"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Shanghai Biomedicine M&amp;A Fund Acquires Stake in MicroPort via Share Transfer Agreement - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"The Shanghai Biomedicine Merger and Acquisition Fund under SIIC Capital has entered into a share transfer agreement to acquire 135,335,204 shares of MicroPort Scientific Corp. (HKG: 0853) from Otsuka Medical Devices Co., Ltd., a subsidiary of Otsuka Holdings. This transaction positions the Shanghai Biomedicine M&amp;A Fund as a strategic shareholder of MicroPort.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=38090\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Shanghai Biomedicine M&amp;A Fund Acquires Stake in MicroPort via Share Transfer Agreement\" \/>\n<meta property=\"og:description\" content=\"The Shanghai Biomedicine Merger and Acquisition Fund under SIIC Capital has entered into a share transfer agreement to acquire 135,335,204 shares of MicroPort Scientific Corp. (HKG: 0853) from Otsuka Medical Devices Co., Ltd., a subsidiary of Otsuka Holdings. This transaction positions the Shanghai Biomedicine M&amp;A Fund as a strategic shareholder of MicroPort.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=38090\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-29T04:17:15+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-29T04:17:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/2905.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38090#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38090\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Shanghai Biomedicine M&amp;A Fund Acquires Stake in MicroPort via Share Transfer Agreement\",\"datePublished\":\"2025-07-29T04:17:15+00:00\",\"dateModified\":\"2025-07-29T04:17:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38090\"},\"wordCount\":171,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38090#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/2905.webp\",\"keywords\":[\"Finance\",\"HKG: 0853\",\"MicroPort Scientific\",\"Otsuka Medical Devices\",\"Shanghai Biomedicine\"],\"articleSection\":[\"Company\",\"Deals\",\"Medical Device\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=38090#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38090\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=38090\",\"name\":\"Shanghai Biomedicine M&amp;A Fund Acquires Stake in MicroPort via Share Transfer Agreement - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38090#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38090#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/2905.webp\",\"datePublished\":\"2025-07-29T04:17:15+00:00\",\"dateModified\":\"2025-07-29T04:17:16+00:00\",\"description\":\"The Shanghai Biomedicine Merger and Acquisition Fund under SIIC Capital has entered into a share transfer agreement to acquire 135,335,204 shares of MicroPort Scientific Corp. (HKG: 0853) from Otsuka Medical Devices Co., Ltd., a subsidiary of Otsuka Holdings. This transaction positions the Shanghai Biomedicine M&A Fund as a strategic shareholder of MicroPort.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38090#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=38090\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38090#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/2905.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/2905.webp\",\"width\":1080,\"height\":608,\"caption\":\"Shanghai Biomedicine M&A Fund Acquires Stake in MicroPort via Share Transfer Agreement\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=38090#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shanghai Biomedicine M&amp;A Fund Acquires Stake in MicroPort via Share Transfer Agreement\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Shanghai Biomedicine M&amp;A Fund Acquires Stake in MicroPort via Share Transfer Agreement - Insight, China&#039;s Pharmaceutical Industry","description":"The Shanghai Biomedicine Merger and Acquisition Fund under SIIC Capital has entered into a share transfer agreement to acquire 135,335,204 shares of MicroPort Scientific Corp. (HKG: 0853) from Otsuka Medical Devices Co., Ltd., a subsidiary of Otsuka Holdings. This transaction positions the Shanghai Biomedicine M&A Fund as a strategic shareholder of MicroPort.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=38090","og_locale":"en_US","og_type":"article","og_title":"Shanghai Biomedicine M&amp;A Fund Acquires Stake in MicroPort via Share Transfer Agreement","og_description":"The Shanghai Biomedicine Merger and Acquisition Fund under SIIC Capital has entered into a share transfer agreement to acquire 135,335,204 shares of MicroPort Scientific Corp. (HKG: 0853) from Otsuka Medical Devices Co., Ltd., a subsidiary of Otsuka Holdings. This transaction positions the Shanghai Biomedicine M&A Fund as a strategic shareholder of MicroPort.","og_url":"https:\/\/flcube.com\/?p=38090","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-07-29T04:17:15+00:00","article_modified_time":"2025-07-29T04:17:16+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/2905.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=38090#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=38090"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Shanghai Biomedicine M&amp;A Fund Acquires Stake in MicroPort via Share Transfer Agreement","datePublished":"2025-07-29T04:17:15+00:00","dateModified":"2025-07-29T04:17:16+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=38090"},"wordCount":171,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=38090#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/2905.webp","keywords":["Finance","HKG: 0853","MicroPort Scientific","Otsuka Medical Devices","Shanghai Biomedicine"],"articleSection":["Company","Deals","Medical Device"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=38090#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=38090","url":"https:\/\/flcube.com\/?p=38090","name":"Shanghai Biomedicine M&amp;A Fund Acquires Stake in MicroPort via Share Transfer Agreement - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=38090#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=38090#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/2905.webp","datePublished":"2025-07-29T04:17:15+00:00","dateModified":"2025-07-29T04:17:16+00:00","description":"The Shanghai Biomedicine Merger and Acquisition Fund under SIIC Capital has entered into a share transfer agreement to acquire 135,335,204 shares of MicroPort Scientific Corp. (HKG: 0853) from Otsuka Medical Devices Co., Ltd., a subsidiary of Otsuka Holdings. This transaction positions the Shanghai Biomedicine M&A Fund as a strategic shareholder of MicroPort.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=38090#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=38090"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=38090#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/2905.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/2905.webp","width":1080,"height":608,"caption":"Shanghai Biomedicine M&A Fund Acquires Stake in MicroPort via Share Transfer Agreement"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=38090#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Shanghai Biomedicine M&amp;A Fund Acquires Stake in MicroPort via Share Transfer Agreement"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/07\/2905.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/38090","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=38090"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/38090\/revisions"}],"predecessor-version":[{"id":38093,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/38090\/revisions\/38093"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/38092"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=38090"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=38090"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=38090"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}